Diabetes Product Review: New Eversense Implantable CGM

If you have diabetes, you already know that every shiny new gadget promises to “change everything.” Sometimes it does. Sometimes it just gives you one more app notification and a stronger relationship with adhesive remover. The new Eversense implantable CGM, now known as Eversense 365, is one of the rare devices that genuinely feels different. Not slightly different. Not “same sandwich, new wrapper” different. Actually different.

Why? Because this continuous glucose monitor does not ask you to swap out a sensor every week or two. Instead, the sensor is implanted under the skin of your upper arm by a healthcare professional and is designed to last up to a full year. In the world of diabetes technology, that is a pretty dramatic plot twist.

But longer does not automatically mean better for every person. A year-long CGM sounds fantastic until you remember a few details: there is still a transmitter on your skin, there is still adhesive in the picture, and yes, fingerstick calibration has not fully packed its bags and left town. So the real question is not whether Eversense 365 is impressive. It clearly is. The better question is whether it fits real life.

This review takes a close look at the new Eversense implantable CGM, including features, comfort, accuracy, convenience, downsides, and who may benefit most. If you are comparing long-term CGM options, wondering whether the office procedure is worth it, or simply curious about whether one sensor per year is as magical as it sounds, here is the full breakdown.

What Is the New Eversense Implantable CGM?

Eversense 365 is a long-term implantable continuous glucose monitor for adults with diabetes. Unlike traditional CGMs that sit on top of the skin with a short-wear sensor, Eversense places a tiny sensor under the skin of the upper arm during an in-office procedure. A removable, rechargeable smart transmitter then sits on the skin above that implanted sensor and sends glucose data to a mobile app.

The system is built around three main parts: the implanted sensor, the wearable smart transmitter, and the smartphone app. Together, they deliver real-time glucose readings, trend data, and alerts for highs and lows. The transmitter also offers on-body vibration alerts, which is a big deal for people who do not keep their phone attached to their hand like a second limb.

This is also where Eversense stands apart from many other CGMs. The sensor is long-term, but the transmitter is removable. That means you can take the transmitter off when needed without “wasting” the implanted sensor. There is a catch, of course: when the transmitter is off, you are not collecting glucose data or receiving alerts from it. So it is flexible, but not magical.

Why Eversense 365 Is Getting So Much Attention

One sensor for a full year

The headline feature is obvious. Eversense 365 is designed to last up to 365 days, which puts it in a completely different category from traditional short-term CGMs. For anyone tired of counting down sensor expiration dates, reordering supplies, or discovering at the worst possible time that a sensor peeled off early, the appeal is immediate.

It is implantable, not disposable every other week

Most CGM systems ask users to repeat the same ritual over and over: remove old sensor, clean skin, place new sensor, wait through warmup, hope the adhesive behaves, and move on. Eversense replaces that frequent cycle with a clinician-led insertion and a much longer use period. For some people, that means less mental clutter. Diabetes already runs enough background processes without adding “sensor replacement day” every ten days.

It is built for fewer everyday annoyances

The company positions Eversense 365 as a solution to several familiar CGM frustrations: sensors getting knocked off, wear-time failures, harsh adhesive reactions, and nighttime false alerts. That does not mean it will erase all inconvenience, but it does change the type of inconvenience. Instead of frequent sensor changes, you trade for a procedure, a wearable transmitter, and a calibration routine.

How Eversense 365 Works in Real Life

Insertion day

The sensor is inserted just under the skin of the upper arm by a trained healthcare provider. It is a small in-office procedure, usually involving a tiny incision that is closed with Steri-Strips rather than full stitches. For people who hate needles, this may sound like a hard pass. But compared with replacing external sensors over and over again all year, some users may see this as one concentrated inconvenience instead of dozens of mini-hassles.

The daily routine

Once the sensor is in place, the day-to-day experience centers on the transmitter and the app. The transmitter sits on the arm above the sensor using a silicone-based adhesive patch that is changed daily. That daily patch change is worth emphasizing because Eversense is not a fully “set it and forget it” system. The implanted sensor is long-term, but the wearable piece still needs attention.

The upside is flexibility. The transmitter is removable and rechargeable, and the system offers vibration alerts directly on the body. That means you can still get important warnings when your phone is not nearby. It also means you can take the transmitter off temporarily when needed, such as during a break from wear, although glucose data collection pauses when it is not on your arm.

Calibration is lighter, not gone

Here is the part where the hype meets reality. Eversense 365 still requires fingerstick calibration. The startup period includes more frequent calibration, and after day 13 the system generally moves to once-weekly calibration. That is a major improvement over the earlier Eversense E3 system, which required daily calibration after its startup window, but it is still more maintenance than factory-calibrated CGMs that mostly skip this step.

So yes, Eversense 365 reduces the fingerstick burden compared with older implantable versions. No, it does not turn fingersticks into an ancient myth told around the campfire.

Accuracy, Safety, and Performance

Accuracy matters more than marketing slogans, and Eversense 365 has clinical data worth paying attention to. In the ENHANCE study, the system showed an overall mean absolute relative difference, or MARD, of 8.8% through one year. In plain English, that places it in the accuracy range people expect from modern CGM technology and makes it competitive enough to be taken seriously by both clinicians and experienced CGM users.

The study also reported strong alert performance, with confirmed detection rates of 96.6% at 70 mg/dL and 97.9% at 180 mg/dL. Sensor survival through the full 365 days was 90%, and no related serious adverse events were reported in the study. Those are meaningful numbers, especially for a device asking patients to commit to a much longer sensor life than usual.

That said, all CGMs have limitations. Eversense is approved to replace routine fingersticks for diabetes treatment decisions, but backup blood glucose testing is still part of the real-world picture when symptoms do not match the readings or when calibration is needed. A good CGM should increase confidence, not convince you to stop thinking.

Pros of the New Eversense Implantable CGM

• Extremely long sensor life: One insertion can cover up to a full year, which dramatically reduces the frequency of sensor changes.
• Removable transmitter: You can remove and replace the transmitter without losing the implanted sensor.
• On-body vibration alerts: Helpful for people who want alerts even when the phone is not in hand.
• Competitive accuracy: The clinical data are solid and make Eversense 365 more than just a novelty.
• Potentially fewer adhesion disasters: Daily patch changes and the implantable design may reduce some of the classic “my sensor fell off at the grocery store” drama.
• Less supply churn: Fewer sensor replacements can mean less ordering, less storage, and less device waste over time.

Cons of the New Eversense Implantable CGM

• It requires a procedure: Insertion and removal must be done by a trained healthcare professional.
• It still uses adhesive: If you were hoping to break up with adhesives forever, this is not that breakup.
• Calibration is still required: Weekly calibration after day 13 is lighter than older versions, but it is still more work than some competing CGMs.
• Adults only: Eversense 365 is approved for people 18 and older, which limits access for pediatric users.
• Not ideal for the commitment-phobic: A one-year device sounds convenient, but it also means your CGM choice is less casual than peeling one off and trying another brand next week.

Eversense 365 vs Traditional CGMs

The easiest way to understand Eversense 365 is to stop asking whether it is “better” in a universal sense and start asking what kind of burden you would rather carry.

Traditional CGMs usually win on simplicity at the beginning. You insert them yourself at home. Many are factory calibrated. There is no office procedure. If you want maximum independence and minimal setup drama, that can be very appealing.

Eversense 365 wins on longevity and wear philosophy. Instead of replacing sensors every 7 to 15 days, you get a far longer sensor life and a removable transmitter. That can mean fewer interruptions, fewer supply headaches, and a different kind of comfort for people who are exhausted by constant device turnover.

So the tradeoff looks like this: traditional CGMs are usually easier to start, while Eversense 365 may be easier to live with over the long haul for the right person. It is less about which one is universally superior and more about which one annoys you less.

Who Might Love Eversense 365

Eversense 365 may be a great fit for adults who want long-term consistency, dislike frequent sensor changes, or have had issues with external sensors falling off too early. It may also appeal to people who want vibration alerts on-body, like the idea of a removable transmitter, or are simply tired of building life around short sensor wear cycles.

People who are very organized about appointments and appreciate a “one big setup, long payoff” approach may find this system especially appealing. It can also be attractive to users who want a more stable long-term CGM experience and are willing to accept weekly calibration as part of the deal.

Who Might Prefer Another CGM

If you strongly prefer self-insertion at home, want to avoid any office procedure, or are determined to minimize fingersticks as much as possible, a traditional factory-calibrated CGM may still be the better choice. The same goes for anyone who wants the freedom to switch devices frequently or who knows that daily adhesive maintenance is a nonstarter.

There is also a psychological angle here. Some people love the idea of a year-long sensor. Others hear “implanted for a year” and immediately want to leave the room. Both reactions are fair. Diabetes tech should match your comfort level, not challenge it to a duel.

Coverage, Cost, and Practical Access

Coverage is improving, and official patient resources say Eversense 365 is covered by most commercial health plans for many insulin users and is also available for Medicare beneficiaries who meet criteria. There are also promotional savings programs advertised by the manufacturer for eligible commercially insured users. Still, actual out-of-pocket cost depends on insurance rules, provider billing pathways, and whether the insertion procedure is bundled or billed separately.

In other words, do not judge this device by a single price line on a marketing page. Judge it by what your plan, your doctor, and your pharmacy or supplier say after the paperwork dust settles.

Final Verdict: Is the New Eversense Implantable CGM Worth It?

The new Eversense implantable CGM is one of the most interesting diabetes technology launches in years because it does not merely improve an old idea by 10%. It changes the rhythm of CGM use. One sensor for up to a year is a meaningful shift in how people may think about continuous glucose monitoring.

Its biggest strengths are obvious: unmatched wear duration, a removable transmitter, on-body vibration alerts, and strong clinical accuracy data. Its biggest drawbacks are equally clear: an in-office insertion and removal procedure, continued adhesive use, and weekly calibration after the startup phase.

So is it worth it? For the right adult with diabetes, absolutely. Especially for someone who is tired of short-term sensors, frequent failures, or constant replacement cycles. But it is not automatically the best CGM for every user. Eversense 365 is not the easiest option. It may, however, be the most appealing option for people who want fewer interruptions over time and are willing to pay for that convenience with a little upfront complexity.

Think of it this way: if traditional CGMs are the weekly meal prep of diabetes tech, Eversense 365 is the giant Sunday batch cook. More effort at the start, less daily chaos later. And for some people, that trade is exactly the point.

Longer-Term Experience: What Living With Eversense 365 May Feel Like

One of the most useful ways to judge the Eversense 365 is to imagine not the launch day, but month three, month six, and month eleven. That is where this device either becomes a beloved sidekick or an overcomplicated roommate.

In the first week, the experience is usually shaped by novelty. There is the insertion appointment, the setup process, the calibrations, and the mild fascination of realizing your CGM sensor is under the skin rather than hanging on for dear life with external adhesive. Some people may feel immediate relief because they know they are not facing another sensor replacement in ten days. That emotional benefit is easy to underestimate. Diabetes management is not just physical; it is logistical. Reducing repetitive device chores can genuinely lighten the mental load.

As the weeks pass, Eversense 365 likely becomes less about “wow, futuristic” and more about routine. The transmitter goes on, the daily adhesive gets changed, the app shows trends, and life moves along. That normalcy is probably the product’s biggest hidden strength. The device is not trying to impress you every day. It is trying to stop interrupting you every day.

Nighttime may be another area where the experience feels different. Users who have struggled with alarms from a sensor getting compressed during sleep may appreciate the implanted design. And the on-body vibration alerts add another layer of reassurance because your phone does not have to be physically glued to your palm for the system to get your attention.

There are still tradeoffs. Some users may find the daily adhesive patch mildly annoying, especially if they hoped “implantable” meant “zero skin maintenance.” Others may not love remembering weekly calibration after the startup phase. And some people simply do better with a device they can start and stop at home without scheduling an office visit. Those are not deal-breakers for everyone, but they are real parts of the experience.

Over the long run, though, Eversense 365 seems built for a very specific emotional win: reducing friction. Fewer sensor changes. Fewer wasted sensors. Fewer moments where a device quits early and takes your patience down with it. If that kind of steadiness matters more to you than having a completely procedure-free setup, the system may feel less like a flashy new gadget and more like a practical upgrade to daily life.

And honestly, that may be the best compliment possible for diabetes tech. Not that it feels futuristic. Not that it looks cool. Just that it quietly makes an already demanding condition a little less annoying.